Related Experiment Video

Updated: Apr 18, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K

Integrating epigenetic and immune biomarkers to enable dynamic precision therapy in triple-negative breast cancer

Jabed Iqbal1, Sue-Zann Chua2

  • 1Division of Pathology, Singapore General Hospital, Singapore.

Expert Review of Molecular Diagnostics
|April 16, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Triple-negative breast cancerartificial intelligenceepigenetic biomarkersimmune biomarkersliquid biopsyprecision oncologyspatial transcriptomics

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 18, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.5K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

A randomized controlled trial evaluating a novel individualized treatment strategy for carbapenem-resistant Gram-negative bacteria infections.

International journal of antimicrobial agents·2026

Case Report: Post-mortem analysis of long-term inflammation after mild COVID-19.

Frontiers in immunology·2026

An Agreement Study of Stromal Cellularity, Stromal Cell Atypia, and Tumor Border of Phyllodes Tumors of the Breast.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma.

Virchows Archiv : an international journal of pathology·2026

Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Science translational medicine·2026

Cancer Burden in Bangladesh: Insights From National Institute of Cancer Research & Hospital, 2014-2020.

JCO global oncology·2026

Nanotheranostics in orthopedic diseases: a critical review of molecular diagnostic-driven targeted therapeutics for personalized patient care.

Expert review of molecular diagnostics·2026

Molecular events underlying sarcoma development and progression: the diagnostic relevance.

Expert review of molecular diagnostics·2026

Culture-free genomics: a shift toward genome-wide applications in Chagas disease and leishmaniasis.

Expert review of molecular diagnostics·2026

Innovations in the diagnosis of Pythium insidiosum keratitis: molecular advances and the path to point-of-care testing.

Expert review of molecular diagnostics·2026

Respiratory viral co-detection in the multiplex era: a critical perspective on diagnostic stewardship and anti-infective decision-making.

Expert review of molecular diagnostics·2026

Salivary biomarkers as a non-invasive diagnostic tool for gastric cancer: a systematic review and meta-analysis.

Expert review of molecular diagnostics·2026

Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.

medRxiv : the preprint server for health sciences·2026

Engineered subtilisin protease degrades active KRAS in cancer cells leading to differential cell targeting.

Research square·2026

Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.

Research square·2026

The therapy-conditioned host: a state-transition framework for second primary cancer evolution.

Frontiers in oncology·2026

Cyclopeptide 161 protects human dermal fibroblasts against UV-induced damage via the MEK1/2-ERK1/2 signaling pathway.

Frontiers in physiology·2026

Dynamic clonal evolution of multiple bypass resistance mechanisms in EGFR-mutant lung adenocarcinoma: a case report.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us